CAS: 893449-38-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PRL-3 Inhibitor REF: IN-DA0086O7CAS: 893449-38-2 | 98% | To inquire | Mon 16 Dec 24 | |
PRL-3 Inhibitor I REF: 7W-GL7783CAS: 893449-38-2 | - - - | To inquire | Tue 17 Dec 24 | |
PRL-3 Inhibitor I REF: TM-T22136CAS: 893449-38-2 | 100% | 34.00 €~828.00 € | Mon 23 Dec 24 | |
5-[[5-Bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone REF: TR-B680650CAS: 893449-38-2 | - - - | 1,570.00 € | Fri 24 Jan 25 | |
PRL-3 Inhibitor I REF: 3D-TKB44938CAS: 893449-38-2 | Min. 95% | - - - | Discontinued product |
PRL-3 Inhibitor
CAS:893449-38-2
Formula:
C17H11Br2NO2S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
485.2127
Ref: IN-DA0086O7
1g | To inquire | ||
50mg | 185.00 € | ||
100mg | 234.00 € | ||
250mg | 652.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
PRL-3 Inhibitor I
CAS:893449-38-2
PRL-3 Inhibitor I (BR-1) is a phosphatase of regenerating liver 3 (PRL-3) inhibitor which blocks …
Formula:
C17H11Br2NO2S2
Purity:
100%
Color and Shape:
Solid
Molecular weight:
485.21
Ref: TM-T22136
5mg | 34.00 € | ||
10mg | 52.00 € | ||
25mg | 93.00 € | ||
50mg | 141.00 € | ||
100mg | 203.00 € | ||
200mg | 305.00 € | ||
1mL*10mM (DMSO) | 41.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
5-[[5-Bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone
Controlled ProductCAS:893449-38-2
Formula:
C17H11Br2NO2S2
Color and Shape:
Neat
Molecular weight:
485.213
Ref: TR-B680650
100mg | 1,570.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
PRL-3 Inhibitor I
CAS:893449-38-2
PRL-3 inhibitor I is a chemical inhibitor that binds to the protein tyrosine phosphatase (PTP) …
Formula:
C17H11Br2NO2S2
Purity:
Min. 95%
Molecular weight:
485.21 g/mol
Ref: 3D-TKB44938
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |